• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)


Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer.

Dr. Fiorotti holds a Ph.D. in Microbiology and Immunology and has worked in drug development for 19 years, with combined experience from both Sponsor and CRO organizations. She brings a comprehensive perspective to the business development endeavors at Immunologix and is uniquely positioned to serve as CCO.

"We are fortunate to have someone of Dr. Fiorotti's caliber and experience step up to lead the commercial operation, including the business development team, at Immunologix" said Michael Anderson, President and CEO. "Corinna is strategically positioned for the role of CCO as she has a deep understanding of our business from both the scientific and business points of view and brings a strong track record of business success. As a member of our unique Translational Sciences team at Immunologix for the past 2 years, Dr. Fiorotti has built an in-depth understanding of our services and the market. She is a strong communicator who is customer focused and possesses operational and leadership capabilities to successfully execute on the company's strategy and growth plans"

Related Videos
Related Content